FDA Inspection 1065132 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Jul 31, 2018 in Rockville Centre, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 31, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville Centre, NY (United States)